Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
Gelmon
K A
KA
British Columbia Cancer Agency, Vancouver, BC, Canada. kgelmon@bccancer.bc.ca
Eisenhauer
E A
EA
Harris
A L
AL
Ratain
M J
MJ
Workman
P
P
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*
D000970:Antineoplastic Agents; D015507:Drugs, Investigational